FLNA

Filana Therapeutics

153 hedge funds and large institutions have $332M invested in Filana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

24% less capital invested

Capital invested by funds: $439M → $332M (-$107M)

43% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 42

Holders
153
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$133M
Puts
$105M
Net Calls
Net Calls Change

Top Buyers

1 +$5.9M
2 +$3.76M
3 +$3.13M
4
Goldman Sachs
Goldman Sachs
New York
+$2.96M
5
N
Nuveen
North Carolina
+$2.91M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$4.14K
127
$4K
128
$3.57K
129
$3K
130
$3K
131
$2.81K
132
$2.54K
133
$2.34K
134
$2.22K
135
$2K
136
$1.48K
137
$1.48K
138
$1.48K
139
$1.48K
140
$1.15K
141
$1K
142
$1K
143
$739
144
$591
145
$414
146
$354
147
$295
148
$148
149
$60
150
$13